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Infection of larvae by Autographa californica M nuclear polyhedrosis virus (AcMNPV) results in liquefaction of susceptible
hosts, presumably due to the breakdown of cells and extracellular matrices. In Spodoptera frugiperda tissue culture cells,
infection leads to dramatic rearrangement and eventual destruction of the actin cytoskeleton. The first of these rearrange-
ments is the formation of actin cables in the cytoplasm of the cell. Cable formation requires release of the budded virus
(BV) nucleocapsid from the endosome, but does not require new protein synthesis, suggesting that the nucleocapsid contains
the activity necessary to induce cable formation. We have identified two distinct BV-associated actin-targeting activities.
The first, a nucleocapsid-associated actin-binding activity, enabled actin copelleting and may also induce actin polymerization
and cable formation. The second activity, associated with the nucleocapsid and envelope fractions of BV, was a protease
that specifically degraded actin. This protease was identified as V-CATH, a cathepsin L-like protease that is a product of
the AcMNPV v-cath gene. q 1996 Academic Press, Inc.
INTRODUCTION Actin-binding proteins regulate actin’s ability to poly-
merize and/or interact with other proteins (Pollard and
Autographa californica M nuclear polyhedrosis virus Cooper, 1986). The major capsid protein of AcMNPV, p39,
(AcMNPV) is an enveloped, double-stranded DNA virus and an unidentified protein from infected cell extracts
that infects lepidopteran larvae. AcMNPV has two distinct are preferentially retained on a filamentous actin affinity
phenotypes; one is occluded and the other is not. Occlu- column (Charlton and Volkman, 1991). It is not known,
sion-derived virus (ODV) is responsible for transmission however, if these proteins interact directly with actin or
of infection between insects. Budded virus (BV) is respon- bind through other, unidentified actin-binding proteins.
sible for spread of infection within an insect and is 1800- In this report, we present evidence of at least two distinct
fold more infectious in cell culture than ODV (Volkman activities that interact with actin. One activity, identified
et al., 1976). This difference in infectivity can be attributed using actin copelleting assays, bound actin and was as-
to the envelope protein, gp64, which is present in BV and sociated with the BV nucleocapsid. This activity inter-
absent in ODV. BV enters cells by adsorptive endocyto- acted with both monomeric and filamentous actin and
sis, and gp64’s fusogenic activity is required for release may induce actin polymerization and cable formation.
of the nucleocapsid from the endosome into the cyto- The other activity was a protease that targeted actin and
plasm (Volkman and Goldsmith, 1985; Blissard and Wenz, was associated with both the nucleocapsid and envelope
1992). Shortly after release of the nucleocapsid from the fractions of BV. We present strong evidence that this
endosome, ‘‘cables’’ of polymerized actin appear in the protease is viral cathepsin (V-CATH), the product of the
cytoplasm (Charlton and Volkman, 1993). These cables AcMNPV v-cath gene. Finally, V-CATH was not required
appear to extend from the cytoplasm to the nuclear mem- for cable formation but may be involved in the breakdown
brane, and nucleocapsids are often seen associated with of the host cell cytoskeleton and the cytopathic effects
one end of the cables (Charlton and Volkman, 1993). of infection.
Cable formation requires release of the nucleocapsid
from the endosome but does not require protein synthe- MATERIALS AND METHODS
sis, suggesting that the nucleocapsid contains the activ-
Cell culture and virus purificationity required to induce cable formation. This activity is
likely to involve at least one actin-binding protein. Concentrated virus used in these studies was pro-
duced by infecting Spodoptera frugiperda Sf9 cells
(ATCC CRL 1711) at a multiplicity of infection (m.o.i.) of1 To whom correspondence and reprint requests should be ad-
dressed. 3 with third-passage wild-type E2 strain AcMNPV (Smith
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and Summers, 1978) or with a recombinant virus that was carried out with the IODOBEAD reagent (Pierce).
First, the IODOBEADs (1 bead/mg actin) were rinsed withcontains an inactivating deletion in the v-cath gene (cath-)
(Slack et al., 1995). Concentrated batches of wild-type 10 mM Tris, pH 7.0. 125I (250 mCi/mg actin) was diluted
in 100–200 ml of 10 mM Tris, pH 7.0, and incubated withand cath- BV as well as controls from mock-infected
cells were prepared in parallel. Log phase cells were the rinsed IODOBEADs for 5 min at room temperature.
The monomeric actin was then added directly to the 125I-centrifuged for 5 min at 1000 rpm in a Beckman table-
top centrifuge and resuspended to a density of 1 1 107 IODOBEAD mixture and incubated for 15 min at room
temperature. After iodination, unincorporated 125I wascells/ml in Grace’s medium (JRH Biosciences) with 10%
fetal calf serum (Gemini Bioproducts) and 0.1% pleuronic separated from 125I-actin by gel filtration on a 5-ml Presto
column (Pierce). Fractions of 250 ml were collected, theF-68. The viral inoculum was added and the cells were
gently rotated (about 75 rpm) for 4 hr, after which more peak fractions pooled, and the actin concentration was
determined as described. Thus prepared, the cpm/mlmedium was added to bring the cells to a final density
of 1 1 106 cells/ml. For mock infection, medium without were directly proportional to the mg/ml of actin in each
fraction. Iodinated actin was stored at 47 for not morevirus was substituted for viral inoculum. The final volume
was 100 ml in a 250-ml shaker flask or 1.5 liters in a 4- than 1 week. At the concentrations used in these studies,
monomeric or globular actin (G actin) in g buffer (10 mMliter Bellco spinner flask. The cells were continuously
rotated at 110 rpm for 48 hr at 287 and then pelleted by Tris, pH 8.5, 0.5 mM ATP, 0.2 mM CaCl2) will not polymer-
ize in the absence of MgCl2 . Polymerization is inducedcentrifugation as described above. BV was harvested
from the cleared medium by centrifugation for 30 min at by the addition of 201 initiation mix to form f buffer (final
concentration, 10 mM Tris, pH 8.5, 2.0 mM ATP, 0.2 mM24,000 rpm in a Beckman SW28 rotor. The virus pellets
were resuspended in 10 mM Tris, pH 8.5, and pelleted CaCl2 , 2.0 mM MgCl2). Although additional ATP is added,
only the addition of MgCl2 is required to induce polymer-through a 25% sucrose cushion to remove residual de-
bris. The final virus pellet was resuspended in 10 mM ization. For reactions with filamentous actin (F actin), 201
initiation mix was added to G actin (2–4 mg/ml, approxi-Tris, pH 8.5. An aliquot of the virus was solubilized with
1% NP-40 and the protein concentration was determined mately 50–100 mM) and the actin was polymerized on
ice for a minimum of 1 hr before dilution directly into theusing the BCA reagent (Pierce), a modified Lowery assay.
The final pellet from mock-infected cells was diluted in proteolysis or pelleting assay.
the same final volume as the pellet from wild-type in-
fected cells and generally contained concentrations of Pelleting and proteolysis assays and analysis
protein below that detectable by the BCA assay. Glycerol
was added to a final concentration of 50% and the stock All reactions were done in a final volume of 100 ml in
Beckman airfuge tubes. Unless otherwise noted, 100 mgvirus stored at 0207 in a nondefrosting freezer until
needed. Before use in any of the assays, the virus was of virus was used in each assay (approximately 1 1
1011 virus particles; Volkman et al., 1976). Reactions werediluted 1:2 in 10 mM Tris, pH 8.5, centrifuged at 80,000
g (34,000 rpm in a Beckman SW60 rotor or 22 psi in done in either g or f buffer, as indicated, in a final volume
of 100 ml with a final concentration of 5 mM actin (100a Beckman airfuge) for 30 min, and the BV pellet was
resuspended in 10 mM Tris, pH 8.5. BV was solubilized ml of 5 mM actin  3 1 1014 molecules actin). Where
noted, protease inhibitors were added just before addi-with 1% NP-40 (sBV), and, where indicated, nucleocap-
sids (NC) were pelleted by centrifugation as described tion of actin. The protease inhibitors tested included the
cysteine protease inhibitors E-64 (10–40 mg/ml, 28–112for BV and resuspended in 10 mM Tris, pH 8.5. The
supernatant fraction contained envelope and tegument mM), Antipain dihydrochloride (50–200 mg/ml, 74–296
mM), and Leupeptin (5–20 mg/ml, 1-4 mM); the metallo-proteins (ENV).
protease inhibitors EDTA (0.5 mg/ml, 1.3 nM) and Phos-
phoramidon (330 mg/ml, 0.6 mM); the serine proteaseActin purification and iodination
inhibitors Aprotinin (2 mg/ml, 0.3 mM), Pefabloc (1 mg/
ml, 4 nM), and Chymostatin (100 mg/ml, 0.17 mM); theActin was purified from rabbit muscle as described
(Pardee and Spudich, 1982), aliquoted, and stored at aspartate protease inhibitor Pepstatin (1.0 mg/ml, 1.4
mM); and the aminopeptidase inhibitor Bestatin (40 mg/0807 as monomeric actin in a modified buffer A (10 mM
Tris, pH 8.5, 0.2 mM CaCl2 , 0.2 ATP, 0.2 mM DTT). For ml, 130 mM) (Boehringer Mannheim). After the incubation,
all assay mixtures (except those for the localization ofiodination, an aliquot of actin was thawed overnight at
47 and centrifuged for 1 hr at 34,000 rpm (80,000 g) in the proteolytic activity) were centrifuged 30 min in a Beck-
man airfuge at 22 psi (about 80,000 g). The supernatanta Beckman SW60 rotor to remove any filamentous or
denatured actin. The concentration of monomeric actin fractions were removed and the pellets were resus-
pended in 100 ml of the same buffer used in the reactionwas determined by measuring the absorbance at 290
nm (extinction coefficient, 26,600 cm01 M01). Iodination and recentrifuged. The supernatant fractions were
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pooled and one-fifth volume of 51 SDS–PAGE sample
buffer (Sambrook et al., 1989) was added. Pellet fractions
were resuspended in 11 SDS–PAGE sample buffer and
both fractions were boiled for 10 min. For localization of
the proteolytic activity (Fig. 3), one-fifth volume of SDS –
PAGE sample buffer was added immediately after the
incubation period and the samples were boiled for 10
min. Aliquots were removed to determine the cpm/ml.
The samples were then electrophoresed on a 10% SDS –
PAGE gel (Sambrook et al., 1989), fixed in 7% acetic acid/
25% methanol, and dried for exposure on a Phosphor-
Imager.
Cell lysates and extracts
FIG. 1. Actin copelleting with solubilized BV. 125I-labeled mono-
meric actin (G actin in g buffer), polymerizing actin (G actin in fCell lysates for Western blotting were produced by
buffer), or polymerized actin (F actin in f buffer) was incubated aloneinfecting 7 1 105 IPLB Sf21 cells (Vaughn et al., 1977) at
or with solubilized BV (sBV) for 30 min. After incubation, the mixture
a m.o.i. of 20 in a 35-mm dish with 0.5 ml of wild-type or was centrifuged and the cpm in supernatant and pellet fractions
cath- inoculum. Uninfected cells were treated in parallel determined. The cpm in the pellet fraction is expressed as a percent-
age of the total cpm.with 0.5 ml of medium without virus (for Sf21 cells, no
pleuronic acid was added). The dishes were gently
rocked for 4 hr and then 2 ml of medium was added.
were developed using the SuperSignal chemilumines-After 24 hr at 287, the medium was removed and the cells
cence reagent (Pierce) and exposed to film.were rinsed with cold phosphate-buffered saline (PBS)
and then lysed in 11 SDS–PAGE sample buffer and
Fluorescence microscopyboiled for 10 min. Uninfected cell extract used for pread-
sorption of V-CATH antiserum was produced by lysing 1 Individual acid-washed glass coverslips (22 mm2) were
1 107 Sf21 cells in 2 ml of lysis buffer (150 mM NaCl, 50 placed in wells of a six-well tissue culture dish and 5 1
mM Tris, pH 8.5, 0.1% NP-40), sonicating for a total of 80 105 Sf21 cells in 0.25 ml of medium was pipetted on top
sec, and centrifuging for 30 min at 15,000 rpm in a Beck- of each coverslip and allowed to adhere for 1 hr. The
man SW60 rotor. medium was then removed and replaced with wild-type
or cath- BV at an m.o.i. of 200 in 0.25 ml of medium. For
Western blotting uninfected controls, 0.25 ml of medium without virus was
used. After 1 hr, the inoculum was removed, the cov-Samples analyzed for detection of V-CATH by Western
erslips rinsed with medium, and 1.0 ml of medium wasblotting included 300 mg BV, nucleocapsid and envelope
added. The medium was removed at 3 hr postinfectionfractions from 300 mg of BV, and cell lysates from 2 1
(hpi) and the cables were visualized as described (Charl-105 cells. Samples analyzed for detection of p39 and
ton and Volkman, 1993), with the following modifications:gp64 consisted of 10% of the supernatant and 100% of the
centrifugation of the cells onto the coverslip was omitted,pellet fractions from the corresponding pelleting assays.
cells were solubilized with 0.15% NP-40 in PBS, and ca-Samples were electrophoresed on a 10% SDS–PAGE
bles were labeled with 1.5 mM fluorescein- or rhodamine-gel and transferred to nitrocellulose. After transfer, the
labeled phalloidin and visualized by fluorescence.membrane was blocked for 1 hr in blocking buffer (2.3%
(w/v) nonfat dried milk, 0.5% (w/v) BSA, 0.1% (v/v) Tween-
RESULTS20, 0.5% (v/v) NP-40). Rabbit antiserum to V-CATH (Slack
et al., 1995) was preadsorbed for several hours in 1 ml Actin copelleting
of uninfected cell extract and then diluted to a final dilu-
tion of 1:250 in blocking buffer. Monoclonal antibodies Actin copelleting assays were used to determine
whether BV components could interact directly with actin.to p39 (Whitt and Manning, 1988) and gp64 (Keddie et
al., 1989) were also diluted 1:250 in blocking buffer. Goat Iodinated monomeric or filamentous actin was incubated
alone or with solubilized BV, and then the mixture wasanti-rabbit and goat anti-mouse horseradish peroxidase-
conjugated secondary antibodies (Sigma) were diluted centrifuged and the radioactivity in the pellet fractions
determined. Only 0.08% of the monomeric actin (G actin1:3000 in blocking buffer. The blots were incubated with
primary and secondary antibodies for 1 hr each with 30- in g buffer) pelleted on its own (Fig. 1). Addition of 100
mg of solubilized BV increased the amount of actin thatmin rinses with Tris-buffered saline in between incuba-
tions and before signal development. The rinsed blots pelleted to 0.62%, an 8-fold increase. When MgCl2 was
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added to induce polymerization during the reaction (G
actin in f buffer), 0.17% of the actin pelleted on its own
and 4.84% pelleted with sBV (a 28-fold difference). If pre-
polymerized actin was used, and the incubation was
done under polymerizing conditions (F actin in f buffer),
0.29% of the total actin pelleted in the absence of sBV,
while 8.58% pelleted in the presence of sBV, a 30-fold
difference. Given that the BV nucleocapsids were com-
pletely pelleted (see below), and correcting for the
amount of actin that pelleted on its own, the BV particle-
to-actin molecule ratio in the pellets was estimated to
be 1:16 for G actin in g buffer, 1:140 for G actin in f buffer, FIG. 3. Proteolytic activity in nucleocapsid and envelope fractions of
and 1:250 for F actin in f buffer. The increased actin BV. 125I-labeled monomeric actin in polymerizing buffer was incubated
alone or with BV, solubilized BV (sBV), BV nucleocapsids (NC), or BVpelleting observed with sBV was not due merely to the
envelopes (ENV) for 30 min. After incubation, the samples were ana-increased protein concentration, as addition of 100 mg
lyzed by SDS–PAGE and autoradiography on a PhosphorImager. Posi-of BSA to actin in the absence of sBV did not increase tion of prestained molecular weight markers is indicated.
actin pelleting (data not shown). Furthermore, prepara-
tions from mock-infected cells did not affect actin pel-
leting (data not shown). Together these results sug- BV. Both the solubilized BV and the nucleocapsid fraction
gested that a component of BV bound both monomeric increased actin copelleting 6- to 7-fold above the actin
and filamentous actin, enabling the actin to copellet with alone control (Fig. 2A). In contrast, intact BV and the
the BV nucleocapsid. envelope fraction pelleted approximately the same
To confirm that the actin-binding activity was associ- amount of actin as the actin alone control. Western blot
ated with the BV nucleocapsid, BV was fractionated into analysis confirmed the fractionation of BV; the envelope
nucleocapsid and envelope components prior to con- protein, gp64, was in the supernatant fraction of all solu-
ducting the copelleting assays. Controls included actin bilized BV samples, while the capsid protein, p39, was
alone as well as actin incubated with intact or solubilized in the pellet fraction of all but the envelope samples (Fig.
2B). Furthermore, capsid protein was not detected in the
supernatant fraction (data not shown), indicating that the
nucleocapsids were quantitatively pelleted. These re-
sults strongly suggested that the actin copelleting activity
was associated with the BV nucleocapsid.
Actin proteolysis by BV
When 125I-labeled actin was incubated with BV and
then analyzed directly by SDS–PAGE and autoradiogra-
phy, actin proteolysis was detected (Fig. 3). Similar,
though not identical, patterns of proteolysis were seen
with both monomeric or filamentous actin (data not
shown). To localize the actin proteolytic activity within
the virion, BV was fractionated into nucleocapsid and
envelope components prior to conducting the proteolysis
assay. Controls included actin alone as well as actin
incubated with intact or solubilized BV. Solubilized BV
and BV nucleocapsids had similar levels of proteolytic
FIG. 2. Localization of actin copelleting activity to the nucleocap- activity (Fig. 3). Moreover, the proteolytic activity ap-
sid. 125I-labeled monomeric actin in polymerizing buffer was incu-
peared to partition equally between the nucleocapsidbated alone or with intact BV, solubilized BV (sBV), BV nucleocapsid
and envelope fractions. These data suggested that BV(NC), or BV envelope fraction (ENV) for 30 min. After incubation,
the mixture was centrifuged and the cpm in supernatant and pellet contained a proteolytic activity which targeted both mo-
fractions were determined. Replicates (rep 1, 2) were performed nomeric and filamentous actin. Furthermore, the proteo-
simultaneously. (A) Actin copelleting expressed as percentage of lytic activity was associated with both the nucleocapsid
total cpm in pellet. (B) Western analysis of fractions after centrifuga-
and the envelope components, suggesting it was distincttion. gp64 in the supernatant fraction and p39 in the pellet fraction
from the exclusively nucleocapsid-associated pelletingare shown to verify fractionation of the virus. Lanes in (B) correspond
to the lanes directly above in (A). activity.
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FIG. 4. Protease inhibitors that block BV-associated actin proteolysis. FIG. 5. Absence of proteolysis in cath- BV. 125I-labeled monomeric
actin in polymerizing buffer was incubated alone or with solubilized125I-labeled monomeric actin in polymerizing buffer was incubated
alone or with solubilized BV (sBV) in the presence of the indicated wild-type BV (wt sBV) or solubilized cath- BV (cath- sBV), in the presence
or absence of a cocktail of cathepsin protease inhibitors (pi) for 30protease inhibitor for 30 min. After incubation, the mixture was centri-
fuged and 10% of the supernatant fraction was analyzed by SDS–PAGE min. After incubation, the mixture was centrifuged and the pellet fraction
analyzed by SDS–PAGE and autoradiography on a PhosphorImager.and autoradiography on a PhosphorImager. Arrows indicate proteolytic
fragments detected in the presence of solubilized BV. Position of Position of prestained molecular weight markers is indicated.
prestained molecular weight markers is indicated.
had been preadsorbed with uninfected cell extract (Fig.
Effect of protease inhibitors on actin proteolysis 6). One band, at 35.5 kDa, was detected only in lysates
of wild-type infected cells. Another band, at 27 kDa, was
To determine what type of protease was degrading detected in lysates from wild-type BV-infected cells and
actin, we tested several different protease inhibitors. Indi- in wild-type BV, and partitioned equally between the nu-
vidual protease inhibitors were added to the reaction cleocapsid and envelope fractions. Bands at 35.5 and 27
after BV was solubilized, immediately before the addition kDa have been identified as precursor and mature forms
of actin and the start of the 30-min incubation. The results of V-CATH, respectively (Slack et al., 1995). These results
indicated that proteolysis was blocked by the cysteine demonstrated that mature V-CATH was a component of
protease inhibitors E-64, Antipain dihydrochloride, and BV and provided strong evidence that V-CATH was the
Leupeptin, as well as by Chymostatin, a serine protease BV-associated actin protease.
inhibitor (Fig. 4). The metalloprotease inhibitors EDTA
and Phosphoramidon, the serine protease inhibitors Actin binding and proteolysis are two distinct
Aprotinin and Pefabloc, the aspartate protease inhibitor activities
Pepstatin, and the aminopeptidase inhibitor Bestatin did
The results of localization experiments indicated thatnot block proteolysis (data not shown). This protease
the actin-binding activity enabling copelleting was local-inhibition profile is characteristic of the cysteine protease
ized to the nucleocapsid fraction while the actin proteo-cathepsin L (Kakegawa et al., 1993).
lytic activity was associated with both the envelope and
the nucleocapsid fractions. To investigate furtherEvidence that V-CATH is the protease targeting actin
whether the two activities were distinct, we tested the
It was recently shown that the product of the AcMNPV ability of cath- BV to pellet actin. We found that neither
v-cath gene, V-CATH, is a cathepsin L-like cysteine prote- a cocktail of cysteine protease inhibitors nor absence of
ase that is inhibited by E-64 and Leupeptin (Slack et al.,
1995). To determine whether the actin protease in BV
was related to V-CATH, we conducted proteolysis experi-
ments with BV that contained a deletion in the v-cath
gene (cath- BV) and did not produce the V-CATH protein
(Slack et al., 1995). The results showed unambiguously
that cath- BV did not degrade actin and therefore that V-
CATH may be the actin protease in BV (Fig. 5).
To determine whether V-CATH was a component of
BV, we conducted Western analysis of wild-type BV, nu-
FIG. 6. Localization of the mature form of V-CATH in wild-type BV.cleocapsids, and envelopes using a polyclonal antiserum
Cell lysates from uninfected (U) cells and wild-type (wt) or cath- infectedto V-CATH (Slack et al., 1995). Cath- BV as well as cell
cells were Western blotted along with wt BV, wt BV nucleocapsidslysates from uninfected, wild-type infected, and cath- in-
(NC), wt BV envelopes (ENV), and cath- BV. Western blots were probed
fected cells were used as controls. Two bands were with antiserum to V-CATH. Positions of prestained molecular weight
readily apparent in all the cell lysates and detectable in markers are indicated. Arrows indicate the positions of V-CATH specific
bands.some of the samples of virus even though the antiserum
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the nucleocapsid from the endosome, but does not re-
quire new protein synthesis. Furthermore, the number of
cables formed is directly proportional to the multiplicity
of infection (Charlton and Volkman, 1993). These obser-
vations suggest that the virus particle itself contains the
factor(s) that causes cable formation. Such a factor(s)
may be expected to physically associate with actin, as
has been demonstrated for several viruses. For example,
proper interaction with actin is required for budding and
release of frog virus 3, murine mammary tumor virus, and
measles virus (Damsky et al., 1977; Murti et al., 1985;
Bohn et al., 1986). Furthermore, vaccinia virus actually
encodes two actin-binding proteins; an 11-kDa basic pro-
FIG. 7. Actin copelleting in the absence of proteolysis. 125I-labeled tein that is required for infection in tissue culture (Hillermonomeric actin in polymerizing buffer was incubated alone or with
and Weber, 1982), and a homologue of the actin-bindingsolubilized wild-type (wt) or cath- BV, in the presence or absence of a
protein profilin, which is not essential for infection incocktail of cathepsin protease inhibitors (pi). After incubation, the mix-
ture was centrifuged and the cpm in supernatant and pellet fractions tissue culture (Blasco et al., 1991). Finally, the Pr65gag
were determined. The cpm in the pellet fraction are expressed as a protein of murine retroviral particles binds the viral nu-
percentage of the total cpm. cleocapsid to the end of actin filaments (Mortara and
Koch, 1989) in a manner reminiscent of BV nucleocapsid
association with actin cables.V-CATH prevented actin copelleting (Fig. 7). We therefore
Actin copelleting has been used to identify proteinsconcluded that BV contained two distinct actin-targeting
that physically associate with actin (for example, seeactivities; one that enabled actin copelleting and was
Glenney et al., 1981; Moon et al., 1993). In the studiesnucleocapsid-associated, and the other, an actin prote-
presented here, little monomeric or filamentous actin pel-ase that was present in both nucleocapsid and envelope
leted on its own. Increased actin copelleting occurred infractions of BV. This proteolytic activity was tentatively
the presence of sBV, however, implying that actin be-identified as V-CATH.
came physically attached to the nucleocapsids. There
was an 8-fold increase in the amount of monomeric actinProteolysis is not required for cable formation
that copelleted with BV nucleocapsids under nonpoly-
The discovery of an actin proteolytic activity associated
merizing conditions and a 30-fold increase in the amount
with BV nucleocapsids was quite provocative because
of prepolymerized actin that copelleted with nucleocap-
previous studies have shown that unstable, irregular ac-
sids under polymerizing conditions. These results sug-
tin filaments are formed in vitro as a result of limited
gested that BV had an affinity for both monomeric and
proteolysis or modification of actin (O’Donoghue et al.,
filamentous actin.
1992; Drewes and Faulstich, 1993; Khaitlina et al., 1993).
It is difficult to know whether the difference between
Intriguingly, the actin cables formed during AcMNPV in-
the 8-fold increase in pelleting observed with monomeric
fection are also irregular in shape and are so unstable
actin and the 30-fold increase observed with filamentous
that they must be visualized in phalloidin-stabilized, un-
actin is entirely attributable to the increased number of
fixed cells (Charlton and Volkman, 1993). Given the simi-
subunits in actin polymers or whether BV nucleocapsids
larity between the actin cables in infected cells and the
have an intrinsically higher affinity for filamentous actin.
filaments formed as a result of in vitro proteolysis, we
The BV particle-to-actin monomer ratio after pelleting
were interested in determining whether V-CATH was in-
was 1:16 for G actin in g buffer, 1:145 for G actin in f
volved in BV-induced actin cable formation. Cables were
buffer, and 1:250 for F actin in f buffer. Under the condi-
clearly seen in both wild-type and cath- infected cells
tions used in the pelleting assay, nucleation (the first step
(Figs. 8A and 8B), but not in uninfected cells (Fig. 8C).
in actin polymerization) and elongation of actin filaments
Furthermore, examination of wild-type and cath- infected
occur relatively slowly (Nishida and Sakai, 1983; Lal et
cells revealed no apparent difference in the number or
al., 1984). Thus, after a 30-min incubation, few filaments
length of the cables formed. The results clearly demon-
will be long enough to pellet on their own (Attri et al.,
strated that V-CATH was not required for cable formation.
1991). It is therefore significant that under the same con-
ditions, incubation with sBV led to a 28-fold increase
DISCUSSION
in actin pelleting. This suggested that sBV induced the
polymerization of actin. Indeed, we have shown in subse-Actin cables form in the cytoplasm of infected cells
shortly after the virus particle enters the cell (Charlton quent experiments not presented here that BV nucleo-
capsids are able to nucleate actin polymerization (Lanierand Volkman, 1993). Cable formation requires release of
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FIG. 8. Cable formation in the absence of V-CATH. Sf21 cells were infected with wild-type (A) or cath- (B) BV at an m.o.i. of 200. At 3 hpi the
cells were detergent extracted and the actin cables (arrows) labeled with fluorescein–phalloidin and visualized by fluorescence. (C) Uninfected
cells labeled with rhodamine– phalloidin. Bar, 5 mm.
and Volkman, manuscript in preparation). In the pelleting in degrading or liquefying the body of the host (Ohkawa
et al., 1994; Slack et al., 1995).assays, the initial BV particle-to-actin monomer ratio was
approximately 1:3000, yet sBV was still able to have a We found that AcMNPV BV contained an actin proteo-
lyzing activity present in both the nucleocapsid and thesignificant effect on actin polymerization. Other proteins
that are known to induce actin polymerization require envelope fractions. This proteolytic activity was inhibited
by the cysteine protease inhibitors E-64, Leupeptin, andratios closer to 1:100 to have a significant effect on actin
polymerization in vitro (for example, Glenney et al., 1981; Antipain dihydrochloride as well as by Chymostatin, a
specific inhibitor of cathepsin L (Kakegawa et al., 1993).Galazkiewicz et al., 1989; Moon et al., 1993); nonetheless,
these proteins are able to affect actin polymerization in Since Slack et al. (1995) had reported that AcMNPV V-
CATH could be inhibited by cysteine protease inhibitors,vivo. It is entirely possible, therefore, that the actin bind-
ing sites on a single BV nucleocapsid could induce local we conducted experiments to determine whether cath-
BV lacked actin proteolytic activity and whether wild-typepolymerization of actin in infected cells. Whether the ac-
tin-binding activity associated with actin copelleting is BV envelope and nucleocapsid components contained
V-CATH. The finding that both were true strongly sug-the same as that which induces cable formation remains
to be determined. It is clear, however, that neither the gested that V-CATH was responsible for the actin proteo-
lytic activity found in wild-type BV and supported theactin-binding activity associated with copelleting nor the
nucleocapsid-associated activity that induces actin cable previous conclusion, based on sequence homology, that
V-CATH is closely related to mammalian cathepsin L. Itformation can be attributed to V-CATH because the ab-
sence of this enzyme had no effect on either activity. should be noted that under the conditions used, only a
fraction of the actin was proteolyzed. This may have beenViral proteases play important roles in the processing
of polyproteins to functional proteins in RNA viruses and due in part to the fact that V-CATH is a relatively minor
component of BV. Furthermore, the experiments reportedin maturation of structural proteins in DNA viruses (Hel-
len and Wimmer, 1992). Few cellular substrates of viral here were done at pH 8.5, while the activity of V-CATH
is optimal at pH 5.0 (Slack et al., 1995). Our results areproteases have been identified, however. Recently, it was
discovered that the adenovirus type 2 protease specifi- consistent with the finding that although optimal proteo-
lytic activity often requires an acidic pH, cathepsins willcally targets actin and other cytoskeletal proteins in vitro
(Tihanyi et al., 1993) and HIV-1 protease cleavage of actin degrade cytoskeletal proteins at near neutral pH (Guinec
et al., 1993). This suggests that V-CATH could target bothin vitro and in vivo has been implicated in the pathology
of HIV infection (Shoeman et al., 1991; Adams et al., intracellular proteins at near neutral pH and extracellular
proteins that exist in an acidic environment (Buck et al.,1992). There are reports of two cathepsin-like proteases
encoded by baculoviruses, one in Bombyx mori nuclear 1992). The discovery that actin may be a natural substrate
for V-CATH in infected cells is intriguing in view of reportspolyhedrosis virus and the other in AcMNPV (Rawlings
et al., 1992; Ohkawa et al., 1994; Slack et al., 1995). There that filamentous actin is an important component of inter-
cellular junctions in insect tissues (Lane and Flores,is a predicted 96.3% amino acid sequence identity be-
tween the two viral proteases and significant homology 1988, 1990). The degradation of these junctions by V-
CATH could contribute to liquefaction of the insect hosts.of the predicted catalytic site regions to mammalian ca-
thepsin L (Slack et al., 1995). Although no natural sub- The finding that both intact BV and the BV envelope
fraction have proteolytic activity suggested that at leaststrate was identified for these viral proteases, viruses
defective in producing the proteases are also defective some of the V-CATH is located in the BV viral envelope
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californica nuclear polyhedrosis virus nucleocapsids into IPLB Sf 21with its active domain exposed to the surface. Since the
cells induces actin cable formation. Virology 197, 245–254.viral envelope is acquired from the plasma membrane
Damsky, C., Sheffield, J., Tuszynski, G., and Warren, L. (1977). Is thereupon budding of the virion, this implies that a subset a role for actin in virus budding? J. Cell Biol. 75, 593–605.
of the V-CATH is localized to the plasma membrane of Drewes, G., and Faulstich, H. (1993). Cooperative effects on filament
infected cells. Indeed, cathepsins are frequently associ- stability in actin modified at the C-terminus by substitution or trunca-
tion. Eur. J. Biochem. 212, 247–253.ated with both endosomal vesicles and plasma mem-
Galazkiewicz, B., Belagyi, J., and Dabrowska, R. (1989). The effect ofbranes (Sloane et al., 1994; Allen and Tracy, 1995; Authier
caldesmon on assembly and dynamic properties of actin. Eur. J.et al., 1995), and cell surface cathepsins have been impli-
Biochem. 181, 607–614.
cated in the dissolution of extracellular matrices (Buck Glenney, J. R., Jr., Kaulfus, P., and Weber, K. (1981). F actin assembly
et al., 1992) and demosomal plaques (Holm et al., 1993). modulated by villin: Ca// dependent nucleation and capping of the
barbed end. Cell 24, 471–480.Furthermore, of all the cathepsins, cathepsin L has the
Guinec, N., Dalet-Fumeron, V., and Pagano, M. (1993). ‘‘In vitro’’ studyhighest capacity to degrade proteins, especially the
of basement membrane degradation by the cysteine proteinases,structural proteins collagen (Kirschke et al., 1982) and
cathepsins B, B-like and L. Digestion of collagen IV, laminin, fibronec-
elastin (Mason et al., 1986), and is the most effective in tin, and release of gelatinase activities from basement membrane
the destruction of basement membranes (Baricos et al., fibronectin. Biol. Chem. Hoppe–Seyler 374, 1135–1146.
1988; Guinec et al., 1993). Membrane-associated and Hellen, C. U., and Wimmer, E. (1992). The role of proteolytic processing
in the morphogenesis of virus particles. Experientia 48, 201–215.intracellular V-CATH could thus specifically target extra-
Hiller, G., and Weber, K. (1982). A phosphorylated basic vaccinia virioncellular matrices and cytoskeletons of infected cells, con-
polypeptide of molecular weight 11,000 is exposed on the surfacetributing to the liquefaction of infected insects.
of mature particles and interacts with actin-containing cytoskeletal
elements. J. Virol. 44, 647–657.
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